Overview
This episode of the Curbsiders Addiction Medicine podcast discusses low-dose buprenorphine (bup) initiation protocols, particularly rapid 4-day starts for patients with opioid use disorder (OUD), including practical tips, challenges, patient education, and implementation in different clinical settings.
Introduction & Guest Backgrounds
- Hosts introduce Dr. Carolyn Shan, Dr. Era Kraso, Nurse Practitioner Amelia Goff, and Dr. Alisa Sokolski.
- Guests work at Oregon Health and Science University in addiction medicine and share backgrounds in infectious disease, psychiatry, internal medicine, and harm reduction clinics.
Fundamentals of Low-Dose Buprenorphine Starts
- Buprenorphine is a partial opioid agonist with high receptor affinity, risking precipitated withdrawal if started too soon after fentanyl use.
- Fentanyl’s lipophilicity leads to prolonged retention in tissues, increasing risk of withdrawal with standard bup induction.
- Patient education with visual aids and analogies (e.g., "Gorilla Glue," "walking down stairs") helps explain precipitated withdrawal and gradual induction.
Low-Dose Buprenorphine Initiation Protocols
- Traditional induction requires moderate withdrawal and may not suit patients with pain or fentanyl use.
- Rapid low-dose ("microdosing") protocols allow overlap with full agonist opioids, minimizing withdrawal and accommodating acute pain management.
- Example 4-day protocol: Day 1—bup patch; Day 2—low sublingual doses; Day 3—increased sublingual doses; Day 4—maintenance dose (up to 24-32 mg).
- Institutional and regional differences exist in available bup formulations (patch, sublingual, film).
Patient Selection & Clinical Scenarios
- Low-dose bup starts are especially useful for patients using non-prescribed fentanyl, those with ongoing pain, or those unable to tolerate traditional induction.
- Not ideal for patients on short-acting opioids or very high-dose methadone, where slower induction may be preferred.
- Pregnant patients and those needing rapid transition to extended-release formulations benefit from rapid protocols.
Implementation Challenges & Solutions
- Frequent dosing (e.g., every 3 hours) can be challenging for nursing staff; missed doses may require protocol adjustments.
- Education for nurses, pharmacists, and providers is critical for successful protocol adoption.
- Management includes titrating full agonist opioids and using adjunct meds for withdrawal symptoms.
Outpatient Adaptation & Patient Support
- Outpatient low-dose starts are adapted to available resources; providers cannot prescribe full agonist opioids to manage withdrawal outside the hospital.
- Detailed patient messaging, written instructions, pill-cutting guidance, and close follow-up (via telemedicine and peer support) help ensure adherence.
- Bubble packaging by pharmacies can assist but is not widely available.
Patient Feedback & Takeaways
- Patients report feeling relieved and supported with low-dose protocols as they reduce withdrawal and anxiety.
- Patient education and shared decision-making are emphasized as building trust and protocol success.
- Ongoing research on patient experiences is underway.
Professional Community & Resources
- Importance of professional community support through organizations like the American Society of Addiction Medicine (ASAM) and Echo programs.
- Encouragement for providers in isolated or resource-limited settings to seek out communities and educational resources to reduce burnout.
Decisions
- Adopt rapid 4-day low-dose buprenorphine protocol as standard for suitable hospital patients at OHSU.
Action Items
- TBD – Team: Continue quality improvement and collect feedback for protocol refinement.
- TBD – Pharmacy/Providers: Develop/expand bubble-packaging options for outpatient low-dose inductions.
- TBD – Research Team: Conduct qualitative study on patient experiences with low-dose buprenorphine protocols.
Recommendations / Advice
- Always manage withdrawal, cravings, and pain with adequate full agonist opioids until stable on ≥8 mg buprenorphine.
- Provide thorough education to all patients and clinical staff before and during induction.
- Offer patients choices and remain flexible to adjust protocols based on individual needs.